Summary: Richard Pazdur, MD, director of the U.S. Food and Drug Administration’s Oncology Center of Excellence (OCE), joins Lisa Kennedy Sheldon, PhD, APRN, AOCNP®, FAAN, ONS’s clinical and scientific affairs liaison, to discuss oncology nurses’ contributions to cancer care, OCE’s initiatives, and the COVID-19 coronavirus pandemic’s implications for oncology drug approvals.
